SCHEMBL4577227

SCHEMBL4577227

CN(C=O)c1cc(F)ccc1C1CCN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)CC1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRCP P42785 16/20 0.62
MC4R P32245 4/20 0.58
MC3R P41968 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27392877 0.81 MC4R (0.73) PRCPMC4RMC3R
SCHEMBL5673897 0.80 PRCP (0.64) PRCPMC4RMC3R
SCHEMBL5617397 0.80 MC4R (0.67) PRCPMC4RMC3R
SCHEMBL4577060 0.80 MC4R (0.71) PRCPMC4RMC3R
SCHEMBL4577067 0.80 MC4R (0.71) PRCPMC4RMC3R
SCHEMBL4577252 0.80 MC4R (0.60) PRCPMC4RMC3R
SCHEMBL4577231 0.80 PRCP (0.63) PRCPMC4RMC3R
SCHEMBL4577262 0.79 PRCP (0.58) PRCPMC4RMC3R
SCHEMBL4591654 0.79 PRCP (0.62) PRCPMC4RMC3R
SCHEMBL4958465 0.79 MC4R (0.63) PRCPMC4RMC3R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534074-A4 COMBINATION THERAPY FOR THE TREATMENT OF OBESITY MERCK & CO INC (US) 2008-01-09 EP claimed
EP-1534074-A2 COMBINATION THERAPY FOR THE TREATMENT OF OBESITY Merck & Co., Inc. (US) 2005-06-01 EP claimed
WO-2004009015-A2 COMBINATION THERAPY FOR THE TREATMENT OF OBESITY MERCK & CO., INC. (US) 2004-01-29 WO claimed